Ligand validation:3ASN

PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE

PGV is a Ligand Of Interest in 3ASN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ASN_PGV_C_267	44%	50%	0.25	0.979	0.85	1.08	3	5	8	0	100%	1
3ASN_PGV_A_522	39%	48%	0.27	0.98	0.85	1.16	2	2	1	0	100%	1
3ASN_PGV_P_1267	39%	48%	0.274	0.982	0.92	1.08	3	4	2	0	100%	1
3ASN_PGV_N_1266	34%	43%	0.289	0.978	0.85	1.36	2	6	2	0	100%	1
3ASN_PGV_A_524	6%	36%	0.404	0.849	1.29	1.25	2	7	19	0	100%	1
3ASN_PGV_N_1524	5%	42%	0.395	0.798	1	1.23	2	7	12	0	100%	1
3ASN_PGV_C_268	3%	34%	0.454	0.801	1.27	1.34	2	6	3	0	100%	1
3ASN_PGV_P_1268	2%	31%	0.456	0.76	1.24	1.5	2	6	5	0	100%	1
5B1A_PGV_P_303	98%	35%	0.064	0.985	1.06	1.51	3	13	8	0	100%	1
5X1B_PGV_C_302	95%	52%	0.078	0.981	0.92	0.93	2	4	0	0	100%	1
5B1B_PGV_C_302	94%	56%	0.078	0.979	0.81	0.87	1	1	3	0	100%	1
7YPY_PGV_P_302	94%	54%	0.079	0.978	0.79	0.99	2	2	1	0	100%	1
5ZCQ_PGV_N_608	90%	32%	0.094	0.978	1.15	1.53	5	8	1	0	100%	1
7VUW_PGV_A_608	90%	48%	0.096	0.979	0.89	1.12	2	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.